JXR trims free-float by 1.72 million shares via on-market buyback, treasury stock climbs to 75.12 million

Bulletin Express11-05

Jinxin Fertility Group Limited (JXR) disclosed a fresh share repurchase on 5 November 2026, reducing its issued share count (excluding treasury stock) by 1.72 million shares, or 0.07%, to 2.63 billion. The transaction, executed on the Hong Kong Stock Exchange under the group’s standing buyback mandate, was priced between HKD 2.315 and HKD 2.380 per share, with a volume-weighted average price of HKD 2.342. Aggregate consideration reached HKD 4.03 million.

The acquired shares have been placed in treasury, lifting JXR’s treasury stock balance to 75.12 million shares. Total issued shares—including treasury—remain unchanged at 2.71 billion.

Repurchase capacity • Shareholders renewed the buyback mandate on 25 June 2026, authorising the company to repurchase up to 262.51 million shares. • Cumulative buybacks under this mandate now stand at 87.66 million shares, equivalent to 3.34% of the company’s issued share base on the mandate date. • A 30-day moratorium on new share issues or treasury share disposals is in effect until 5 December 2026, in line with Hong Kong listing rules.

Pending cancellations Separately, 92.47 million shares repurchased between March and August 2026 remain earmarked for cancellation but were still outstanding at the latest reporting date. These shares were acquired at volume-weighted average prices ranging from HKD 1.97 to HKD 2.47 per share.

Strategic context The continued execution of share repurchases indicates management’s ongoing utilisation of its authorised mandate to adjust the company’s capital structure. While total issued share capital is unchanged due to treasury accounting, the reduction in free-floating shares marginally increases earnings per share for existing shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment